• 11-Dehydro-Thromboxane B2, Urine
  • Chloride, Urine
  • Impetigo
  • T-Cell Antigen Receptor, Gamma (TRG@) Gene Rearrangement Analysis for Abnormal Clonality, Amplified Method, Bone Marrow
  • Bordetella pertussis Antibody, IgG
  • HLA Class I and II typing, Antigen or Genotyping
  • Histoplasma capsulatum Antigen, CSF
  • Antinuclear Antibody (ANA), Body Fluid
  • Fabry (Anderson) disease
  • Osmolality, Body Fluid
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /CYFRA 21-1 (Cytokeratin 19 Fragment), Serum
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

CYFRA 21-1 (Cytokeratin 19 Fragment), Serum
Medical Test

Methodology
Access to CYFRA 21-1 (Cytokeratin 19 Fragment), Serum is restricted.